ArticleOncoTargets and therapy2015

A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy.

Casey B Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.